AI Neither Adds nor Detracts From Chemo in This Setting AI Neither Adds nor Detracts From Chemo in This Setting
The addition of endocrine deprivation therapy to neoadjuvant chemotherapy doesn ' t increase pathologic complete response rates in hormone receptor-positive, HER2-positive breast cancer, but it doesn ' t diminish the effectiveness of chemotherapy either, as has long been believed.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Health | Hematology | HER2 | Hormones | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy